Thrombin Receptor Antagonists for the Treatment of Atherothrombosis: Therapeutic Potential of Vorapaxar and E-5555

Author： Leonardi Sergio   Tricoci Pierluigi   Becker Richard C.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.14, 2010-10, pp. : 1771-1783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A.   Popik P.   Bespalov A.Y.   Danysz W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

By Kowalski Timothy J   McBriar Mark D  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1113-1122

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan   Guglin Maya   Vaitkevicius Peter   Ghali Jalal K.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite

Discovery and therapeutic potential of kinin receptor antagonists

By Whalley Eric T   Figueroa Carlos D   Gera Lajos   Bhoola Kanti D  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1129-1148

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E.   Noll G.   Lüscher T.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite